PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

Publication ID:

MLI02232497

Publication Date:

November 30, 2022

Pages:

Publisher:

麻豆原创Line

Countries:

USA [1]

USD 175.00

Company Reports (Pharma & Healthcare) [2]

Pharma & Healthcare [3]

Description:

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360藲 view of the company.

Key Highlights

PDL Biopharma, Inc. (PDL or 'the company') manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income-generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. The company is headquartered in Reno, Nevada, the US

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.

Table Of Contents:

Table of Contents
Company Snapshot
PDL Biopharma, Inc.: Company Overview
PDL Biopharma, Inc.: Overview and Key Facts
PDL Biopharma, Inc.: Overview
PDL Biopharma, Inc.: Key Facts
PDL Biopharma, Inc.: Key Employees
PDL Biopharma, Inc.: Key Employee Biographies
PDL Biopharma, Inc.: Major Products and Services
PDL Biopharma, Inc.: Company History
PDL Biopharma, Inc.: Key Competitors
PDL Biopharma, Inc.: Company Analysis
PDL Biopharma, Inc.: Business Description
PDL Biopharma, Inc.: SWOT Analysis
PDL Biopharma, Inc.: SWOT Overview
PDL Biopharma, Inc.: Strengths
PDL Biopharma, Inc.: Weaknesses
PDL Biopharma, Inc.: Opportunities
PDL Biopharma, Inc.: Threats
PDL Biopharma, Inc.: Corporate Financial Deals Activity
PDL Biopharma, Inc.: Financial Deals Overview
PDL Biopharma, Inc.: Targets and Partners
PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
PDL Biopharma, Inc.: Advisors
PDL Biopharma, Inc.: Top Financial Advisors
PDL Biopharma, Inc.: Mergers and Acquisitions
PDL Biopharma, Inc.: Corporate Venturing
PDL Biopharma, Inc.: Divestments
PDL Biopharma, Inc.: Recent Developments
PDL Biopharma, Inc.: News and Events Summary
PDL Biopharma, Inc.: Contracts
PDL Biopharma, Inc.: Corporate Governance
PDL Biopharma, Inc.: Financial Performance
PDL Biopharma, Inc.: Red Flags/DistressSignals
PDL Biopharma, Inc.: Regulatory and Legal Events
PDL Biopharma, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About 麻豆原创Line

List of Tables
List Of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Company History
Table 4: PDL Biopharma, Inc.: Key Competitors
Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 6: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: PDL Biopharma, Inc.: Targets and Partners
Table 8: PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
Table 9: PDL Biopharma, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 11: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 12: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 13: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 14: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)
Table 15: PDL Biopharma, Inc.: News and Events Summary
Table 16: PDL Biopharma, Inc.: Contracts
Table 17: PDL Biopharma, Inc.: Corporate Governance
Table 18: PDL Biopharma, Inc.: Financial Performance
Table 19: PDL Biopharma, Inc.: Red Flags/DistressSignals
Table 20: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 21: PDL Biopharma, Inc.: Strategy and Operations

List of Figures
List Of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 2: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 4: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 5: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 6: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 7: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.